Tumor-infiltrating lymphocytes (TILs) were isolated from control and NR4A1-treated mice (low-dose groups), and the percentage CD8+ and CD4+ T-cells and Treg cells were determined by flow cytometry. The gene discussed is CD8A; the disease is neoplasm.